<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2017.00178</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Ehrlichia chaffeensis</italic> Tandem Repeat Effector Targets Differentially Influence Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Luo</surname> <given-names>Tian</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/414717/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Dunphy</surname> <given-names>Paige S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>McBride</surname> <given-names>Jere W.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/16429/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pathology, University of Texas Medical Branch</institution> <country>Galveston, TX, USA</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Microbiology and Immunology, University of Texas Medical Branch</institution> <country>Galveston, TX, USA</country></aff>
<aff id="aff3"><sup>3</sup><institution>Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch</institution> <country>Galveston, TX, USA</country></aff>
<aff id="aff4"><sup>4</sup><institution>Sealy Center for Vaccine Development, University of Texas Medical Branch</institution> <country>Galveston, TX, USA</country></aff>
<aff id="aff5"><sup>5</sup><institution>Institute for Human Infections and Immunity, University of Texas Medical Branch</institution> <country>Galveston, TX, USA</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Matthew S. Francis, Ume&#x000E5; University, Sweden</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Ulrike G. Munderloh, University of Minnesota, USA; Damien F. Meyer, Agricultural Research Centre for International Development, France; Cecilia Tamborindeguy, Texas A&#x00026;M University, USA</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Jere W. McBride <email>jemcbrid&#x00040;utmb.edu</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>05</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>7</volume>
<elocation-id>178</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>02</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>04</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Luo, Dunphy and McBride.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Luo, Dunphy and McBride</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p><italic>Ehrlichia chaffeensis</italic> infects mononuclear phagocytes and survives intracellularly by exploiting host cell processes to evade host defenses. The mechanisms involved are not fully defined, but appear to rely largely on a subset of tandem repeat proteins (TRP) effectors. <italic>E. chaffeensis</italic> TRPs are type 1 secreted effectors that interact with a functionally diverse group of host cell targets associated with various biological processes. In this study, we investigated the influence of TRP host target proteins on ehrlichial infection by RNA interference. In total, 138 TRP-interacting host proteins identified by yeast two-hybrid were targeted by siRNA and the infection level determined by real-time qPCR. Knockdown of 124 (89%) TRP target proteins had significant influence on infection either by inhibiting (85%) or promoting (15%) ehrlichial infection. Notably, knockdown of 18 host proteins which interacted with TRP120 promoted the infection, suggesting that these targets may be degraded to promote infection. Host proteins that interact with TRPs are involved in cellular processes, including cell signaling, vesicle trafficking and intracellular transport, transcriptional regulation, metabolism, protein posttranslational modification, and apoptosis. Selected host targets were examined by immunofluorescent microscopy during infection and were found to localize with the morulae, or in the host cell cytoplasm adjacent to morulae. This study confirms that the majority of host proteins known to interact with TRP effectors influence infection and further extends the current knowledge that <italic>E. chaffeensis</italic> TRPs participate in a complex array of host protein interactions in order to reprogram the host cell and promote intracellular survival.</p>
</abstract>
<kwd-group>
<kwd><italic>Ehrlichia chaffeensis</italic></kwd>
<kwd>tandem repeat protein</kwd>
<kwd>effector-host interaction</kwd>
<kwd>infection</kwd>
<kwd>cell signaling</kwd>
<kwd>vesicle trafficking</kwd>
<kwd>transcriptional regulation</kwd>
<kwd>posttranslational modification</kwd>
</kwd-group>
<contract-num rid="cn001">AI106859</contract-num>
<contract-num rid="cn001">AI126144</contract-num>
<contract-sponsor id="cn001">National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100000060</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="7"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="16"/>
<word-count count="9706"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p><italic>Ehrlichia chaffeensis</italic> is an obligately intracellular bacterium and the etiologic agent of the emerging life-threatening human zoonosis, human monocytotropic ehrlichiosis (HME) (Paddock and Childs, <xref ref-type="bibr" rid="B36">2003</xref>). <italic>E. chaffeensis</italic> selectively infects mononuclear phagocytes and resides in endosome-like membrane-bound vacuoles where it replicates and evades innate host defenses (Paddock and Childs, <xref ref-type="bibr" rid="B36">2003</xref>). The mechanisms by which <italic>E. chaffeensis</italic> enters the host cell, avoids destruction, and establishes persistent infection are not well-understood, but functionally relevant host-pathogen interactions are essential for reprogramming the host cell defense mechanisms. This molecular strategy involves type 1 secreted tandem repeat protein (TRP) effectors (Lina et al., <xref ref-type="bibr" rid="B26">2016b</xref>).</p>
<p><italic>E. chaffeensis</italic> TRPs are major immunoreactive proteins that elicit strong host antibody responses during infection. The tandem repeat (TR) domains in TRP120, TRP47, and TRP32 are acidic, serine-rich, and contain protective species-specific epitopes (Doyle et al., <xref ref-type="bibr" rid="B8">2006</xref>; Luo et al., <xref ref-type="bibr" rid="B32">2008</xref>, <xref ref-type="bibr" rid="B31">2009</xref>; Kuriakose et al., <xref ref-type="bibr" rid="B23">2012</xref>). TRP120 and TRP47 are differentially expressed by infectious dense cored cells (DC), while TRP32 is expressed by both DCs and replicating reticulate cells (RC) (Popov et al., <xref ref-type="bibr" rid="B37">2000</xref>; Doyle et al., <xref ref-type="bibr" rid="B8">2006</xref>; Luo et al., <xref ref-type="bibr" rid="B32">2008</xref>). Consistent with type 1 secretion (T1S) signals identified in the C-terminal domains of TRPs, TRPs have been experimentally identified as T1S system substrates through studies using a heterologous T1S apparatus of <italic>Escherichia coli</italic> (Wakeel et al., <xref ref-type="bibr" rid="B42">2011</xref>).</p>
<p>In order to identify <italic>Ehrlichia</italic>-host interactions and help define the complex mechanisms by which <italic>E. chaffeensis</italic> modulates host cells, multiple studies using the yeast two-hybrid (Y2H) approach have been performed to better understand molecular host-pathogen interactions involving TRPs. TRP120, TRP47, and TRP32 have been shown to interact with a diverse network of host proteins involved in many host cellular processes including cell signaling, vesicle trafficking and intracellular transport, transcriptional regulation, metabolism, posttranslational modification and apoptosis, indicating the important roles of TRPs in reprogramming the host cell (Wakeel et al., <xref ref-type="bibr" rid="B43">2009</xref>; Luo et al., <xref ref-type="bibr" rid="B29">2011</xref>; Luo and McBride, <xref ref-type="bibr" rid="B30">2012</xref>).</p>
<p>TRPs are modified by multiple host posttranslational modification pathways, including SUMOylation, ubiquitination and phosphorylation, which appear to mediate functional interactions and extend the number and diversity of interactions with host targets, as well as localization to various subcellular locations, including the nucleus (Wakeel et al., <xref ref-type="bibr" rid="B44">2010</xref>; Dunphy et al., <xref ref-type="bibr" rid="B9">2014</xref>). TRP120 is modified by SUMO at a canonical consensus SUMO conjugation motif located in the C-terminal domain, which has been further confirmed using a high-density microfluidic peptide array (Zhu et al., <xref ref-type="bibr" rid="B51">2016</xref>). TRP120 conjugation with SUMO mediates interactions with host protein targets, and inhibition of the host SUMO pathway significantly decreases interaction between TRP120 and host protein targets, resulting in decreased ehrlichial intracellular survival (Dunphy et al., <xref ref-type="bibr" rid="B9">2014</xref>). TRP120 also interacts with components of the ubiquitin pathways, including the E3 ligases, KLHL12 and FBXW7 as well as ubiquitin (Ub) isoforms UBB and UBC, which suggests TRP120 is a target of Ub conjugation (Luo et al., <xref ref-type="bibr" rid="B29">2011</xref>). TRP47 is phosphorylated and interacts with the Src family tyrosine kinase, Fyn, which may be involved in the tyrosine phosphorylation of TRP47 (Wakeel et al., <xref ref-type="bibr" rid="B43">2009</xref>, <xref ref-type="bibr" rid="B44">2010</xref>). TRPs also contain many additional predicted phosphorylation sites; however, it is not clear which protein kinases are involved and how the phosphorylation affects TRP function or interactions with the host cell.</p>
<p>We have demonstrated the influence of selected TRP120 or TRP32-interacting host proteins on ehrlichial infection by RNA interference (Luo and McBride, <xref ref-type="bibr" rid="B30">2012</xref>; Luo et al., <xref ref-type="bibr" rid="B28">2016</xref>); however, a comprehensive analysis of all TRP-host interactions has not been performed. In this study, we extend the role of TRP-host interactions by investigating the influence of 138 TRP120, TRP47, and TRP32 interacting host target proteins on ehrlichial infection by RNA interference. We directly demonstrate that <italic>E. chaffeensis</italic> exploits the host cells through complex TRP interactions with a large and diverse array of host targets to promote intracellular survival.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Cell culture and cultivation of <italic>E. chaffeensis</italic></title>
<p>Human monocytic leukemia cells (THP-1, from ATCC) were propagated in RPMI medium 1640 with L-glutamine and 25 mM HEPES buffer (Invitrogen, Carlsbad, Invitrogen), supplemented with 1 mM sodium pyruvate, 2.5 g/L D-(&#x0002B;)-glucose (Sigma, St. Louis, MO), and 10% fetal bovine serum (HyClone, Logan, UT). <italic>E. chaffeensis</italic> (Arkansas strain) was cultivated in THP-1 cells as previously described (Kuriakose et al., <xref ref-type="bibr" rid="B22">2011</xref>).</p>
</sec>
<sec>
<title>siRNAs and antibodies</title>
<p>All specific siRNAs were MISSION esiRNA from Sigma, which are endoribonuclease-prepared siRNA pools comprised of a heterogeneous mixture of siRNAs that all target the same mRNA sequence. These multiple silencing triggers lead to highly specific and effective gene silencing (guaranteed &#x0003E; 70% knockdown at the mRNA level) with lower off-target effects than single or pooled siRNAs. Targeting sequences of all siRNAs can be found on Sigma website. The control siRNA was ON-TARGET<italic>plus</italic> non-targeting siRNA from GE Healthcare Dharmacon (Lafayette, CO), which was designed to leverage seed-region optimization and patented modification patterns to have fewer off-targets than traditionally designed, unmodified negative control siRNAs. Thus, changes in mRNA or protein levels in cells treated with the control reflect a baseline cellular response that can be compared to the levels in cells treated with target-specific siRNA. Alexa Fluor 488-labeled negative siRNA was from Qiagen (Germantown, MD). Rabbit and mouse anti-TRP32, TRP47, or TRP120 antibodies have been described previously (Kuriakose et al., <xref ref-type="bibr" rid="B23">2012</xref>). Other antibodies used in this study were mouse anti-human FBXW7 (R&#x00026;D Systems, Minneapolis, MN), &#x003B1;-tubulin and PTPN2 (Santa Cruz, Dallas, TX), and rabbit anti-human CD14 (Abgent, San Diego, CA), EIF3A, ERA1, KARS, LMAN1, and STAT6 (Proteintech, Rosemont, IL), FYN and SLC43A3 (Santa Cruz), IRF2BP2 and SEPX1 (Pierce, Rockford, IL), KDM6B (Novus, Littleton, CO), and RC3H1 (Sigma).</p>
</sec>
<sec>
<title>RNA interference</title>
<p>THP-1 cells (1 &#x000D7; 10<sup>5</sup>/well on a 96-well plate) were transfected with 5 pmol siRNA using Lipofectamine 3000 (Invitrogen) according to the manufacturer&#x00027;s protocol. An Alexa Fluor 488-labeled negative siRNA was used as a control to monitor transfection efficiency. At 1 day posttransfection, the cells were synchronously infected by cell-free <italic>E. chaffeensis</italic> at a MOI of &#x0007E;50, and collected at 1 and 2 days postinfection (p.i.) for Western blot and quantitative PCR (qPCR) to determine knockdown levels and infection status, respectively. The experiment of each siRNA was repeated for at least three times. Infectious dense-cored (DC) ehrlichiae enter the host cell and transform into large replicating reticulate cells (RC). At 1 day p.i. ehrlichiae are represented predominantly by RC and RC ehrlichiae replicate during the next 2 days p.i. before maturing into DC at 3 days. Thus, infected cells were not collected at 3 days p.i. since some cells started to collapse and release <italic>Ehrlichia</italic>.</p>
</sec>
<sec>
<title>Quantification of <italic>E. chaffeensis</italic> by qPCR</title>
<p>THP-1 cells were pelleted, washed by PBS, lysed in SideStep lysis and stabilization buffer (Agilent, Santa Clara, CA) for 10 min at room temperature with shaking, and analyzed for bacterial load using real-time qPCR. Amplification of the integral ehrlichial disulfide bond formation protein (<italic>dsb</italic>) gene and human glyceraldehyde-3-phosphate dehydrogenase (<italic>gapdh</italic>) gene was performed separately using Brilliant II SYBR Green mastermix (Agilent), 200 nM forward primers (<italic>dsb</italic>: 5&#x02032;-gctgctccaccaataaatgtatccct-3&#x02032;; <italic>gapdh</italic>: 5&#x02032;-ggagtccactggcgtcttcac-3&#x02032;) and 200 nM reverse primers (<italic>dsb</italic>: 5&#x02032;-gtttcattagccaagaattccgacact-3&#x02032;; <italic>gapdh</italic>: 5&#x02032;-gaggcattgctgatgatcttgag-3&#x02032;). The qPCR thermal cycling protocol (denaturation at 95&#x000B0;C 10 min, then 40 cycles of 95&#x000B0;C 30 s, 58&#x000B0;C 30 s, 72&#x000B0;C 30 s) was performed on the 7900HT fast real-time PCR system (Applied Biosystems, Foster City, CA). The fold change of <italic>dsb</italic> copy number relative to the control was normalized to qPCR-detected levels of the host <italic>gapdh</italic> gene.</p>
</sec>
<sec>
<title>Western immunoblot</title>
<p>The THP-1 cell lysates were prepared using CytoBuster protein extraction reagent (Novagen/EMD, Gibbstown, NJ), separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membrane. Western immunoblot was performed with horseradish peroxidase-labeled goat anti-rabbit, or mouse IgG (heavy and light chains) conjugate (Kirkegaard &#x00026; Perry Laboratories, Gaithersburg, MD) and SuperSignal West Dura chemiluminescent substrate (Thermo Scientific).</p>
</sec>
<sec>
<title>Immunofluorescence microscopy</title>
<p>Uninfected or <italic>E. chaffeensis-</italic>infected THP-1 cells at 2 days p.i. were collected, and the indirect immunofluorescent antibody assay was performed as previously described (Luo et al., <xref ref-type="bibr" rid="B29">2011</xref>). Fluorescence images were obtained using a BX61 epifluorescence microscope (Olympus, Japan) and the Slidebook 5.0 software (Intelligent Imaging Innovations, Denver, CO).</p>
</sec>
<sec>
<title>Statistics</title>
<p>The statistical differences between experimental groups were assessed with the two-tailed Student&#x00027;s <italic>t</italic>-test, and significance was indicated by a <italic>P</italic> &#x0003C; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Demonstration of knockdown of protein expression by western blot analysis</title>
<p>To verify the knockdown of gene expression by siRNA, 11 target proteins of high priority for the <italic>Ehrlichia</italic>-host interaction study were detected at 2 days posttransfection by Western blot, including six TRP120-interacting proteins eukaryotic translation initiation factor 3 subunit A (EIF3A), Era-like 12S mitochondrial rRNA chaperone 1 (ERA1), F-box and WD repeat domain containing 7 (FBXW7), lysine (K)-specific demethylase 6B (KDM6B), interferon regulatory factor 2 binding protein (IRF2BP2), and selenoprotein X 1 (SEPX1), two TRP47-interacting proteins FYN proto-oncogene Src family tyrosine kinase (FYN) and protein tyrosine phosphatase non-receptor type 2 (PTPN2), and three TRP32-interacting proteins CD14 molecule (CD14), ring finger and CCCH-type domain 1 (RC3H1) and solute carrier family 43 member 3 (SLC43A3). The expression of all these proteins was substantially reduced in specific siRNA-transfected cells, respectively, compared with the unrelated control siRNA-transfected cells, indicating the successful knockdown of gene expression and good efficiency of siRNAs (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Verification of knockdown of TRP-interacting host proteins by Western blot</bold>. THP-1 cells were transfected with each specific or control siRNA and 2 days posttransfection Western blots were performed to determine knockdown efficiency. The &#x003B1;-tubulin was visualized as a control of Western blot.</p></caption>
<graphic xlink:href="fcimb-07-00178-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Impact of knockdown of TRP120-interacting proteins on <italic>E. chaffeensis</italic> survival in host cells</title>
<p>In total, 89 siRNAs available on the market were used to target 89 TRP120-interacting host proteins respectively, and then the impact of each siRNA on ehrlichial infection was assessed by qPCR at 1 and 2 days (Figure <xref ref-type="fig" rid="F2">2</xref>) p.i. Overall, knockdown of 80 (90% of 89) TRP120 target proteins had significant influence on ehrlichial infection, while only 9 (10%) proteins did not. Knockdown of 62 (70%) proteins inhibited ehrlichial infection, whereas knockdown of 18 (20%) proteins promoted ehrlichial infection. At 1 day p.i., the decrease of 39 (44%) proteins decreased <italic>Ehrlichia</italic> infection significantly, whereas the decrease of 11 (12%) proteins increased <italic>Ehrlichia</italic> infection significantly. At 2 days p.i., the decrease of 58 (65%) proteins decreased <italic>Ehrlichia</italic> infection significantly, whereas the decrease of 12 (14%) proteins increased <italic>Ehrlichia</italic> infection significantly (Table <xref ref-type="table" rid="T1">1</xref>). The results indicated that most TRP120-interacting host proteins influence <italic>E. chaffeensis</italic> infection, and most TRP120 target proteins promote <italic>Ehrlichia</italic> infection. Knockdown of some targets largely associated with transcriptional regulation (day 1) increased infection, suggesting that these are downregulated or degraded by <italic>Ehrlichia</italic> to promote infection.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Influence of knockdown of TRP120-interacting proteins on <italic><bold>Ehrlichia</bold></italic> infection</bold>. THP-1 cells were transfected with target or control siRNA, and then infected by <italic>E. chaffeensis</italic>. Infection status was determined by qPCR at 1 and 2 days postinfection, compared to control scrambled siRNA-transfected cells. <italic>E. chaffeensis dsb</italic> gene copy numbers were normalized to host <italic>gapdh</italic> gene. Results were from three independent experiments, and the values were means &#x000B1; standard deviations (<sup>&#x0002A;</sup><italic>P</italic> &#x0003C; 0.05, significantly different from control infection).</p></caption>
<graphic xlink:href="fcimb-07-00178-g0002.tif"/>
</fig>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Impact of TRP120-interacting protein knockdown on <italic><bold>E. chaffeensis</bold></italic> survival in host cells</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Number (percentage) of genes whose knockdown had an impact on <italic>E. chaffeensis</italic> infection</bold></th>
<th valign="top" align="center"><bold>Total</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Inhibition</bold></th>
<th valign="top" align="center"><bold>Promotion</bold></th>
<th valign="top" align="center"><bold>No significant change</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5">By day</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Day 1</td>
<td valign="top" align="center">39 (44%)</td>
<td valign="top" align="center">11 (12%)</td>
<td valign="top" align="center">39 (44%)</td>
<td valign="top" align="center">89</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Day 2</td>
<td valign="top" align="center">58 (65%)</td>
<td valign="top" align="center">12 (14%)</td>
<td valign="top" align="center">19 (21%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Overall</td>
<td valign="top" align="center">62 (70%)</td>
<td valign="top" align="center">18 (20%)</td>
<td valign="top" align="center">9 (10%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">By category of function</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">89</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Vesicle trafficking and intracellular transport</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">20</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Cell signaling</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">17</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Transcriptional regulation</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Metabolism</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Posttranslational protein modification</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">10</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Other miscellaneous</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">10</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>TRP120-interacting proteins include host targets involved in vesicle trafficking and intracellular transport, cell signaling, transcriptional regulation, posttranslational modification, metabolism, and others. In each category, knockdown of most or all target proteins had significant influence on ehrlichial infection, and the knockdown of most proteins caused inhibition of infection, consistent with the overall impact of TRP120-interacting proteins (Table <xref ref-type="table" rid="T1">1</xref>). The results indicated that TRP120 has moonlighting functions through interactions with diverse targets to modulate important host cellular processes to facilitate <italic>Ehrlichia</italic> survival.</p>
</sec>
<sec>
<title>Impact of knockdown of TRP47-interacting proteins on <italic>E. chaffeensis</italic> survival in host cells</title>
<p>In total, 35 siRNAs available on the market were used to target 35 TRP47-interacting host proteins respectively, and then the impact of each siRNA on ehrlichial infection was assessed by qPCR at 1 and 2 days p.i. (Figure <xref ref-type="fig" rid="F3">3</xref>). Overall, knockdown of 31 (89% of 35) TRP47 target proteins had significant influence on ehrlichial infection, while only 4 (11%) proteins did not. Knockdown of 30 (86%) proteins inhibited ehrlichial infection, whereas knockdown of only 1 (3%) protein (polycomb group ring finger 5 [PCGF5]) that also interacted with TRP120 promoted ehrlichial infection. At both 1 and 2 days p.i., only PCGF5 knockdown increased <italic>E. chaffeensis</italic> infection significantly, but the knockdown of 25 (71%) proteins decreased the infection significantly at 1 day p.i., and the knockdown of 26 (74%) proteins negatively affected infection significantly at 2 days p.i. (Table <xref ref-type="table" rid="T2">2</xref>). Therefore, consistent with TRP120-interacting proteins, most TRP47-interacting host proteins play a role in <italic>E. chaffeensis</italic> survival by either inhibiting or promoting the infection; moreover, most TRP47-interacting proteins appear to promote rather than inhibit <italic>Ehrlichia</italic> infection.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Influence of knockdown of TRP47-interacting proteins on <italic><bold>Ehrlichia</bold></italic> infection</bold>. THP-1 cells were transfected with target or control siRNA, and then infected by <italic>E. chaffeensis</italic>. Bacterial number changes were determined by qPCR at 1 and 2 days postinfection, compared to control scrambled siRNA-transfected cells. <italic>E. chaffeensis dsb</italic> gene copy numbers were normalized to host <italic>gapdh</italic> gene. Results were from three independent experiments, and the values were means &#x000B1; standard deviations (<sup>&#x0002A;</sup><italic>P</italic> &#x0003C; 0.05, significantly different from control infection).</p></caption>
<graphic xlink:href="fcimb-07-00178-g0003.tif"/>
</fig>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>Impact of TRP47-interacting protein knockdown on <italic><bold>E. chaffeensis</bold></italic> survival in host cells</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Number (percentage) of genes whose knockdown had an impact on <italic>E. chaffeensis</italic> infection</bold></th>
<th valign="top" align="center"><bold>Total</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Inhibition</bold></th>
<th valign="top" align="center"><bold>Promotion</bold></th>
<th valign="top" align="center"><bold>No significant change</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5">By day</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Day 1</td>
<td valign="top" align="center">25 (71%)</td>
<td valign="top" align="center">1 (3%)</td>
<td valign="top" align="center">9 (26%)</td>
<td valign="top" align="center">35</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Day 2</td>
<td valign="top" align="center">26 (74%)</td>
<td valign="top" align="center">1 (3%)</td>
<td valign="top" align="center">8 (23%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Overall</td>
<td valign="top" align="center">30 (86%)</td>
<td valign="top" align="center">1 (3%)</td>
<td valign="top" align="center">4 (11%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">By category of function</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">35</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Cell signaling</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">10</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Vesicle trafficking and intracellular transport</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">7</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Transcriptional regulation</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">7</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Metabolism</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">6</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Posttranslational protein modification</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">3</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Others</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">2</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>TRP47-interacting proteins include host targets involved in cell signaling, transcriptional regulation, vesicle trafficking and intracellular transport, metabolism and posttranslational modification, consistent with TRP120-interacting proteins. In each category, knockdown of most or all target proteins had significant influence on ehrlichial infection, and the knockdown of majority of these protein caused inhibition of infection, consistent with the overall influence of TRP47-interacting proteins (Table <xref ref-type="table" rid="T2">2</xref>). The results indicated that TRP47 has moonlighting functions through interactions with diverse targets to modulate important host cellular processes to facilitate <italic>Ehrlichia</italic> survival.</p>
</sec>
<sec>
<title>Impact of knockdown of TRP32-interacting proteins on <italic>E. chaffeensis</italic> survival in host cells</title>
<p>In total, 22 siRNAs were used to target 22 TRP32-interacting host proteins respectively, and then the impact of each siRNA on ehrlichial infection was assessed by qPCR (Figure <xref ref-type="fig" rid="F4">4</xref>). Overall, knockdown of 21 (95% of 22) TRP32 target proteins significantly reduced ehrlichial infection, while knockdown of only 1 (5%) protein (transketolase [TKT]) did not have significant impact on infection. None of TRP32-interacting protein knockdowns promoted ehrlichial infection. At 1 day p.i., the decrease in 13 (59%) proteins had a significant negative impact on <italic>Ehrlichia</italic> infection, and at 2 days p.i., the decrease in 21 (95%) proteins had a significant negative impact on <italic>Ehrlichia</italic> infection (Table <xref ref-type="table" rid="T3">3</xref>). The results indicated that almost all TRP32-interacting proteins play a role in <italic>E. chaffeensis</italic> survival by promoting the infection.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Influence of knockdown of TRP32-interacting proteins on <italic><bold>Ehrlichia</bold></italic> infection</bold>. THP-1 cells were transfected with target or control siRNA, and then infected by <italic>E. chaffeensis</italic>. Bacterial number changes were determined by qPCR at 1 and 2 days postinfection, compared to control scrambled siRNA-transfected cells. <italic>E. chaffeensis dsb</italic> gene copy numbers were normalized to host <italic>gapdh</italic> gene. Results were from three independent experiments, and the values were means &#x000B1; standard deviations (<sup>&#x0002A;</sup><italic>P</italic> &#x0003C; 0.05, significantly different from control infection).</p></caption>
<graphic xlink:href="fcimb-07-00178-g0004.tif"/>
</fig>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p><bold>Impact of TRP32-interacting protein knockdown on <italic><bold>E. chaffeensis</bold></italic> survival in host cells</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th/>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Number (percentage) of genes whose knockdown had an impact on <italic>E. chaffeensis</italic> infection</bold></th>
<th valign="top" align="center"><bold>Total</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>Inhibition</bold></th>
<th valign="top" align="center"><bold>Promotion</bold></th>
<th valign="top" align="center"><bold>No significant change</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5">By day</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Day 1</td>
<td valign="top" align="center">13 (59%)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">9 (41%)</td>
<td valign="top" align="center">22</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Day 2</td>
<td valign="top" align="center">21 (95%)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (5%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Overall</td>
<td valign="top" align="center">21 (95%)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1 (5%)</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">By category of function</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">22</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Cell signaling</td>
<td valign="top" align="center">6</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">6</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Metabolism</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">5</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Protein synthesis, modification and degradation</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">4</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Vesicle trafficking and intracellular transport</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">3</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Transcriptional regulation</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;&#x000A0;Apoptosis</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">2</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>TRP32-interacting proteins include host targets involved in cell signaling, metabolism, protein synthesis, modification and degradation, vesicle trafficking and intracellular transport, transcriptional regulation, and apoptosis, similar to TRP120/TRP47-interacting proteins. In each category, knockdown of most or all target proteins significantly reduced <italic>Ehrlichia</italic> infection, consistent with the overall influence of TRP32-interacting proteins (Table <xref ref-type="table" rid="T3">3</xref>). The results indicated that TRP32 plays multiple roles in reprogramming important host cellular processes.</p>
</sec>
<sec>
<title>Overall impact of knockdown of TRP-interacting proteins on <italic>E. chaffeensis</italic> survival in host cells</title>
<p>By Y2H we have previously identified totally 150 host proteins interacting with <italic>E. chaffeensis</italic> TRPs, including 98 proteins with TRP120, 38 proteins with TRP47, and 22 proteins with TRP32, while TRP120 shares 8 common targets with TRP47 and TRP32 (Wakeel et al., <xref ref-type="bibr" rid="B43">2009</xref>; Luo et al., <xref ref-type="bibr" rid="B29">2011</xref>; Luo and McBride, <xref ref-type="bibr" rid="B30">2012</xref>). In this study, 138 (92% of 150) siRNAs were used to reduce the expression of corresponding genes respectively, including 89 siRNAs for TRP120 targets, 35 siRNAs for TRP47 targets, and 22 siRNAs for TRP32 targets. Overall, knockdown of 124 (89% of 138) TRP target proteins had significant influence on ehrlichial infection. Among 124 TRP target proteins, knockdown of 105 (85%) proteins inhibited ehrlichial infection, whereas knockdown of 19 (15%) proteins promoted ehrlichial infection. The inhibition or promotion of ehrlichial survival occurred at different stages of infection (1 or/and 2 days p.i.). For each TRP, target proteins were consistently involved in similar important host cell processes.</p>
</sec>
<sec>
<title>TRP-expressing ehrlichiae colocalize with human target proteins in <italic>E. chaffeensis</italic>-infected THP-1 cells</title>
<p>Previously, we have demonstrated the interactions of many identified target proteins with <italic>E. chaffeensis</italic> TRP120, TRP47, or TRP32 by multiple approaches (Wakeel et al., <xref ref-type="bibr" rid="B43">2009</xref>; Luo et al., <xref ref-type="bibr" rid="B29">2011</xref>; Luo and McBride, <xref ref-type="bibr" rid="B30">2012</xref>). Here we examined host target proteins with well-defined and interesting functions and confirmed the interactions with <italic>E. chaffeensis</italic> TRPs by immunofluorescence assay. Eight target proteins were examined, including three TRP120-interacting proteins EIF3A, ERA1, and KDM6B, three TRP47-interacting proteins signal transducer and activator of transcription 6 (STAT6), lectin mannose binding 1 (LMAN1), and lysyl-tRNA synthetase (KARS), and two TRP32-interacting proteins RC3H1 and SLC43A3. Consistent with our previous reports, double-immunofluorescence labeling of <italic>E. chaffeensis</italic>-infected THP-1 cells revealed seven proteins EIF3A, ERA1, KDM6B, STAT6, KARS, RC3H1, and SLC43A3 exhibited strong colocalization with the morulae (Figures <xref ref-type="fig" rid="F5">5A&#x02013;D,F&#x02013;H</xref>), while LMAN1 localized in the host cell cytoplasm adjacent to the morula membrane (Figure <xref ref-type="fig" rid="F5">5E</xref>). Redistribution of TRP target proteins in <italic>E. chaffeensis</italic>-infected cells compared to uninfected cells was observed. For example, EIF3A, ERAL1, KDM6B, STAT6, KARS, and SLC43A3 were associated with morulae in infected THP-1 cells (Figures <xref ref-type="fig" rid="F5">5A&#x02013;D,F&#x02013;H</xref>), while in uninfected THP-1 cells, EIF3A, ERAL1, KDM6B, and KARS had diffused or punctate distribution mainly in the cytoplasm (Figures <xref ref-type="fig" rid="F5">5A&#x02013;C,F</xref>, insets), and STAT6 and SLC43A3 were distributed throughout the whole cell (Figures <xref ref-type="fig" rid="F5">5D,H</xref>, insets).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Colocalization of TRP120, TRP47, and TRP32 with their interacting host proteins in <italic><bold>E. chaffeensis</bold></italic>-infected THP-1 cells</bold>. Fluorescence microscopy of infected (2 days postinfection) THP-1 cells stained with 4,6&#x02032;-diamidino-2-phenylindole (blue, showing the nucleus), TRP antibody (green), and host protein antibody (red; panels <bold>A&#x02013;H</bold>, respectively) show co-localization of <italic>E. chaffeensis</italic> TRP-labeled morulae with host protein. The insets (panels <bold>A&#x02013;D</bold>,<bold>F</bold>,<bold>H</bold>) show the distribution of EIF3A, ERAL1, KDM6B, STAT6, KARS, and SLC43A3 in uninfected THP-1 cells. Fluorescence images were obtained using an Olympus BX61 epifluorescence microscope. Bar, 10 &#x003BC;m.</p></caption>
<graphic xlink:href="fcimb-07-00178-g0005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In recent years multiple studies from our laboratory have identified numerous <italic>Ehrlichia</italic>-host interactions and determined that <italic>Ehrlichia</italic> TRPs interact with a diverse network of host proteins involved in many host cellular processes including cell signaling, vesicle trafficking and intracellular transport, transcriptional regulation, metabolism, posttranslational modification, and apoptosis (Wakeel et al., <xref ref-type="bibr" rid="B43">2009</xref>; Luo et al., <xref ref-type="bibr" rid="B29">2011</xref>; Luo and McBride, <xref ref-type="bibr" rid="B30">2012</xref>). Previous studies have helped understand the complex mechanisms by which <italic>E. chaffeensis</italic> modulates host cell processes. This study found that knockdown of host proteins that interact with <italic>Ehrlichia</italic> TRPs differentially influence intracellular survival. Figure <xref ref-type="fig" rid="F6">6</xref> illustrates important host cellular processes that <italic>E. chaffeensis</italic> TRPs modulate during infection through interactions with host targets.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>Schematic diagram of important host cellular processes that <italic><bold>E. chaffeensis</bold></italic> tandem repeat proteins modulate during infection</bold>. 1. Bacterial entry: <italic>E. chaffeensis</italic> binds and enters the host cell by phagocytosis. TRPs interact with host cytoskeletal proteins including actins and actin-related proteins, and also exploit host cell signaling (such as Wnt) to facilitate phagocytosis; TRPs also interact with host vesicular trafficking system to help establish an intracellular niche in a membrane-bound vacuole that does not undergo phagolysosomal fusion. 2. Bacterial replication: TRPs are secreted into the intramorular space and translocate into cytosol and nucleus of the host cell, where these effectors interact with diverse host proteins to modulate cell processes, including vesicle trafficking and intracellular transport, cell signaling, transcriptional regulation, posttranslational modification, metabolism, apoptosis, and others in order to avoid host defense system and permit intracellular replication. 3. Bacterial exit: TRPs interact with many apoptosis-associated proteins (some in mitochondria) to induce host cell apoptosis; TRPs also interact with host cytoskeletal proteins to facilitate exocytosis. Red dots show TRPs, including TRP120, TRP47, and TRP32. <italic>Ec, E. chaffeensis</italic>.</p></caption>
<graphic xlink:href="fcimb-07-00178-g0006.tif"/>
</fig>
<p>Notably, <italic>E. chaffeensis</italic> TRPs interact with numerous host proteins associated with cellular signaling pathways, including 17 proteins with TRP120, 10 proteins with TRP47, and six proteins with TRP32, suggesting that infection and replication of <italic>E. chaffeensis</italic> involves TRP exploitation of conserved cell signaling pathways, such as Wnt, Notch, mitogen-activated protein kinase/extracellular signal-regulated kinases (MAPK/ERK), phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin (PI3K/Akt/mTOR), nuclear factor kappa B (NF&#x003BA;B), and cytokine/chemokine-mediated signaling (Table <xref ref-type="table" rid="T4">4</xref>). Wnt and Notch are fundamental cell signaling pathways that play major roles in the regulation of gene expression, cell proliferation and differentiation, and embryonic development (Hayward et al., <xref ref-type="bibr" rid="B17">2008</xref>). Five TRP120-interacting proteins including ADAM metallopeptidase domain 17 (ADAM17), annexin A2 (ANXA2), protein phosphatase 3 regulatory subunit B alpha (PPP3R1), transducin like enhancer of split 4 (TLE4), and G protein subunit beta 1 (GNB1) are signaling molecules of Wnt and Notch pathways. This is consistent with recent studies in which we have used different approaches to demonstrate that Wnt and Notch signaling pathways play important roles in ehrlichial infection, and TRPs mediate ehrlichial invasion and survival through activation and modulation of Wnt and Notch pathways (Luo et al., <xref ref-type="bibr" rid="B28">2016</xref>; Lina et al., <xref ref-type="bibr" rid="B25">2016a</xref>). In this study, we further demonstrated that knockdown of nearly all of TRP-interacting proteins involved in host cell signaling, except two TRP47-interacting proteins, calcium binding protein 39 (CAB39) and immunoglobulin lambda like polypeptide 1 (IGLL1), significantly influenced <italic>E. chaffeensis</italic> survival. These results support the importance of many conserved cellular signaling pathways in ehrlichial survival. For example, G-protein coupled receptor (GPCR) signaling involves a variety of ligands and stimuli and can regulate a highly interconnected network of signal transductions and cellular responses (Roth et al., <xref ref-type="bibr" rid="B39">2015</xref>). We found that six TRP120-interacting proteins including ADAM17, A kinase anchor protein 2 (AKAP2), C-X-C motif chemokine ligand 12 (CXCL12), G protein subunit alpha i2 (GNAI2), G protein pathway suppressor 1 (GPS1), and phosphodiesterase 1B (PDE1B), and one TRP47-interacting protein GNB1 are involved in GPCR signaling. In addition, MAPK signaling is a conserved pathway involved in a variety of fundamental cellular processes (Cargnello and Roux, <xref ref-type="bibr" rid="B5">2011</xref>). It has been reported that p38 MAPK/ERK1/2 are activated at the early stage of <italic>E. chaffeensis</italic> infection, but the activations are subsequently reduced in infected cells compared with those in uninfected cells (Lin and Rikihisa, <xref ref-type="bibr" rid="B24">2004</xref>). We found that six TRP120-interacting proteins GNAI2, GPS1, immunoglobulin kappa constant (IGKC), interleukin 2 receptor subunit gamma (IL2RG), KRAS proto-oncogene GTPase (KRAS), and PPP3R1, four TRP47-interacting proteins cyclin dependent kinase 1 (CDK1), cyclin dependent kinase 10 (CDK10), FYN, and IGKC, and one TRP32-interacting protein, CD14, are involved in MAPK signaling. Knockdown of all these TRP target proteins significantly influenced infection, indicating that GPCR and MAPK signaling pathways are involved in ehrlichial survival. Based on these studies, Wnt, Notch, and MAPK as well as GPCR signaling pathway appear to be major targets of TRP exploitation. Further investigation is needed to understand the specific role of each TRP target and associated pathway(s) in ehrlichial pathobiology.</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p><bold><italic><bold>E. chaffeensis</bold></italic> TRP-interacting host proteins with primary function in cell signaling</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>TRP</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Host protein</bold></th>
<th valign="top" align="left"><bold>Signaling pathway</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="left"><bold>Symbol</bold></th>
<th valign="top" align="left"><bold>Full name</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TRP120</td>
<td valign="top" align="left">ADAM17</td>
<td valign="top" align="left">ADAM metallopeptidase domain 17</td>
<td valign="top" align="left">GPCR, Notch, Hedgehog, EGFR, TGF&#x003B2;, TNF, cytokine/chemokine</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">AKAP2</td>
<td valign="top" align="left">A kinase anchor protein 2</td>
<td valign="top" align="left">GPCR</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">ANXA2</td>
<td valign="top" align="left">Annexin A2</td>
<td valign="top" align="left">Calcium, Wnt, NF&#x003BA;B, IL, EGFR, STAT3</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CXCL12</td>
<td valign="top" align="left">C-X-C motif chemokine ligand 12</td>
<td valign="top" align="left">GPCR, NF&#x003BA;B, chemokine</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">GCSAM</td>
<td valign="top" align="left">Germinal center associated signaling and motility</td>
<td valign="top" align="left">B cell receptor</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">GNAI2</td>
<td valign="top" align="left">G protein subunit alpha i2</td>
<td valign="top" align="left">GPCR, MAPK, chemokine</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">GPS1</td>
<td valign="top" align="left">G protein pathway suppressor 1</td>
<td valign="top" align="left">GPCR, MAPK, JNK</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IFNGR2</td>
<td valign="top" align="left">Interferon gamma receptor 2</td>
<td valign="top" align="left">IFN&#x003B3;, JAK-STAT</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IL2RG</td>
<td valign="top" align="left">Interleukin 2 receptor subunit gamma</td>
<td valign="top" align="left">IL, MAPK, PI3K/Akt, FGFR</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">KRAS</td>
<td valign="top" align="left">KRAS proto-oncogene, GTPase</td>
<td valign="top" align="left">EGFR, MAPK, NF&#x003BA;B, Ras, Rac</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">LGALS1</td>
<td valign="top" align="left">Galectin 1</td>
<td valign="top" align="left">IKK/NF&#x003BA;B</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">PDE1B</td>
<td valign="top" align="left">Phosphodiesterase 1B</td>
<td valign="top" align="left">GPCR, PLC, FGFR, EGFR</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">PPP3R1</td>
<td valign="top" align="left">Protein phosphatase 3 regulatory subunit B, alpha</td>
<td valign="top" align="left">MAPK, Wnt</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">TLE4</td>
<td valign="top" align="left">Transducin like enhancer of split 4</td>
<td valign="top" align="left">Wnt, Notch</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP47</td>
<td valign="top" align="left">BPI</td>
<td valign="top" align="left">Bactericidal/permeability-increasing protein</td>
<td valign="top" align="left">IL, TNF, TLR</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CAB39</td>
<td valign="top" align="left">Calcium binding protein 39</td>
<td valign="top" align="left">PI3K/Akt/mTOR, IGF1R,</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CDK1</td>
<td valign="top" align="left">Cyclin dependent kinase 1</td>
<td valign="top" align="left">p53, MAPK, Hedgehog</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CDK10</td>
<td valign="top" align="left">Cyclin dependent kinase 10</td>
<td valign="top" align="left">MAPK</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">FYN</td>
<td valign="top" align="left">FYN proto-oncogene, Src family tyrosine kinase</td>
<td valign="top" align="left">Fc&#x003B3; receptor, T cell receptor, MAPK, IKK/NF&#x003BA;B, PI3, C-type lectin receptor, VEGF receptor</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">GNB1</td>
<td valign="top" align="left">G protein subunit beta 1</td>
<td valign="top" align="left">GPCR, Ras, Wnt, PI3K/Akt, Hedgehog, CXCR3/4, cytokine</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IGLL1</td>
<td valign="top" align="left">Immunoglobulin lambda like polypeptide 1</td>
<td valign="top" align="left">B cell receptor</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">PRTN3</td>
<td valign="top" align="left">Proteinase 3</td>
<td valign="top" align="left">Cytokine, IL</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">PTPN2</td>
<td valign="top" align="left">Protein tyrosine phosphatase, non-receptor type 2</td>
<td valign="top" align="left">ERK1/2, EGF receptor, IFN&#x003B3;, IL, TNF, IFN, T cell receptor</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP32</td>
<td valign="top" align="left">CD14</td>
<td valign="top" align="left">CD14 molecule</td>
<td valign="top" align="left">IKK/NF&#x003BA;B, MAPK, TLR, LPS</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CD63</td>
<td valign="top" align="left">CD63 molecule</td>
<td valign="top" align="left">Integrin, VEGF</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">RC3H1</td>
<td valign="top" align="left">Ring finger and CCCH-type domain 1</td>
<td valign="top" align="left">NF&#x003BA;B, T cell receptor</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP120/TRP47</td>
<td valign="top" align="left">IGKC</td>
<td valign="top" align="left">Immunoglobulin kappa constant</td>
<td valign="top" align="left">B cell receptor, MAPK, NF&#x003BA;B</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP120/TRP32</td>
<td valign="top" align="left">IGHA1</td>
<td valign="top" align="left">Immunoglobulin heavy constant alpha 1</td>
<td valign="top" align="left">B cell receptor</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IGLL5</td>
<td valign="top" align="left">Immunoglobulin lambda like polypeptide 5</td>
<td valign="top" align="left">B cell receptor</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>An important host cellular process in which many TRP-interacting host proteins are involved is vesicle trafficking and intracellular transport. This process involves 20 TRP120-interacting proteins, seven TRP47-interacting proteins, and three TRP32-interacting proteins. Remarkably, from this group we found a subset of actin-related proteins interacting with <italic>Ehrlichia</italic> TRPs (particularly TRP120), including eight TRP120-interacting proteins and one TRP47-interacting protein (Table <xref ref-type="table" rid="T5">5</xref>). <italic>Ehrlichia</italic> TRPs interact directly with host cytosolic actin gamma 1 (ACTG1) and eight other actin-binding or related proteins, including actin related protein 2/3 complex subunit 2 (ARPC2), CDC42 small effector 2 (CDC42SE2), integrin subunit alpha M (ITGAM), myosin X (MYO10), spectrin alpha erythrocytic 1 (SPTA1), WAS protein family member 2 (WASF2), WD repeat domain 1 (WDR1), and adenylate cyclase associated protein 1 (CAP1), suggesting that actin cytoskeleton plays an important role in ehrlichial infection. Most of these TRP-interacting proteins have also been found to be involved in phagocytosis or endocytosis. Multiple studies have shown the importance of TRP120 in ehrlichial binding and internalization, and most recently, we demonstrated that TRPs directly activate Wnt signaling to induce ehrlichial phagocytosis (Popov et al., <xref ref-type="bibr" rid="B37">2000</xref>; Kumagai et al., <xref ref-type="bibr" rid="B21">2010</xref>; Luo et al., <xref ref-type="bibr" rid="B28">2016</xref>). In addition, it has been reported that <italic>E. chaffeensis</italic> is transported through the filopodia of the host cell and inhibition of actin polymerization in infected cells prevents filopodia formation. Moreover, the spreading process of <italic>Ehrlichia canis</italic> in macrophages is also dependent on actin cytoskeleton (Thomas et al., <xref ref-type="bibr" rid="B41">2010</xref>; Alves et al., <xref ref-type="bibr" rid="B1">2014</xref>). Other studies reported that <italic>E. chaffeensis</italic> surface protein EtpE binds GPI-anchored protein DNase X to trigger entry by N-WASP-dependent actin polymerization (Mohan Kumar et al., <xref ref-type="bibr" rid="B34">2013</xref>, <xref ref-type="bibr" rid="B33">2015</xref>). Therefore, interaction of TRPs with actin cytoskeleton might facilitate ehrlichial entry/release and necessary intracellular trafficking during <italic>Ehrlichia</italic> infection. Our RNAi data showed that knockdown of all these <italic>Ehrlichia</italic> TRP target proteins except WDR1 significantly reduced bacterial load, demonstrating the importance of actin cytoskeleton organization in ehrlichial entry and/or survival.</p>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p><bold><italic><bold>E. chaffeensis</bold></italic> TRP-interacting host proteins with primary function in actin cytoskeleton organization</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>TRP</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Host protein</bold></th>
<th valign="top" align="left"><bold>Function</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="left"><bold>Symbol</bold></th>
<th valign="top" align="left"><bold>Full name</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TRP120</td>
<td valign="top" align="left">ACTG1</td>
<td valign="top" align="left">Actin gamma 1</td>
<td valign="top" align="left">Component of the cytoskeleton and mediator of internal cell motility</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">ARPC2</td>
<td valign="top" align="left">Actin related protein 2/3 complex subunit 2</td>
<td valign="top" align="left">Control of actin polymerization, phagocytosis and endocytosis, vesicle transport, membrane trafficking</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CDC42SE2</td>
<td valign="top" align="left">CDC42 small effector 2</td>
<td valign="top" align="left">F-actin accumulation, phagocytosis, regulation of cell shape</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">ITGAM</td>
<td valign="top" align="left">Integrin subunit alpha M</td>
<td valign="top" align="left">Regulation of actin cytoskeleton, phagocytosis</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">MYO10</td>
<td valign="top" align="left">Myosin X</td>
<td valign="top" align="left">Actin-based molecular motor, integration of F-actin and microtubule cytoskeletons, phagocytosis, intracellular transport, regulation of cell shape</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">SPTA1</td>
<td valign="top" align="left">Spectrin alpha, erythrocytic 1</td>
<td valign="top" align="left">Actin binding and crosslinking, determination of cell shape, molecular scaffold organization of organelles</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">WASF2</td>
<td valign="top" align="left">WAS protein family member 2</td>
<td valign="top" align="left">Actin binding, cytoskeleton organization, phagocytosis</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">WDR1</td>
<td valign="top" align="left">WD repeat domain 1</td>
<td valign="top" align="left">Actin filament binding and fragmentation, disassembly of actin filaments</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP47</td>
<td valign="top" align="left">CAP1</td>
<td valign="top" align="left">Adenylate cyclase associated protein 1</td>
<td valign="top" align="left">Actin polymerization or depolymerization, cell morphogenesis and polarity, endocytosis</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Another group of TRP-interacting proteins with significant interest is host proteins involved in transcriptional regulation, including 16 TRP120-interacting proteins, seven TRP47-interacting proteins, and two TRP32-interacting proteins (Table <xref ref-type="table" rid="T6">6</xref>). These proteins are either transcription factors or transcription regulators (coactivator or corepressor). Both TRP120 and TRP47 interact with PCGF5, a component of the polycomb repressive complex which mediates epigenetic regulation (Gao et al., <xref ref-type="bibr" rid="B13">2014</xref>). Other important TRP120-interacting proteins involved in transcriptional regulation include AT-rich interactive domain 1B (ARID1B), cyclin-dependent kinase 12 (CDK12), interleukin enhancer binding factor 3 (ILF3), IRF2BP2, KDM6B, nuclear receptor binding SET domain protein 1 (NSD1), and tripartite motif containing 24 (TRIM24). Important TRP47-interacting proteins involved in transcriptional regulation include AT-rich interactive domain 2 (ARID2), histone deacetylase 2 (HDAC2), signal transducer and activator of transcription 5A and 6 (STAT5A and STAT6), and transcription factor EC (TFEC). Moreover, TRP32 interacts with DAZ-associated protein 2 (DAZAP2) and hematopoietically expressed homeobox (HHEX). We have previously reported that <italic>Ehrlichia</italic> TRP120 and TRP32 are nucleomodulins that directly bind host DNA and regulate the expression of numerous genes involved with transcriptional regulation, signal transduction, and cell differentiation and proliferation (Zhu et al., <xref ref-type="bibr" rid="B52">2011</xref>; Farris et al., <xref ref-type="bibr" rid="B12">2016</xref>). In this study, our RNAi data showed that knockdown of all <italic>Ehrlichia</italic> TRP target proteins involved in transcriptional regulation significantly influenced infection level, therefore, TRPs also play roles in regulation of host gene transcription by direct interactions with transcription factors and regulators in multiple cellular processes including survival, growth, and differentiation.</p>
<table-wrap position="float" id="T6">
<label>Table 6</label>
<caption><p><bold><italic><bold>E. chaffeensis</bold></italic> TRP-interacting host proteins involved in transcriptional regulation</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>TRP</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Host protein</bold></th>
<th valign="top" align="left"><bold>Main function</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="left"><bold>Symbol</bold></th>
<th valign="top" align="left"><bold>Full name</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TRP120</td>
<td valign="top" align="left">ARID1B</td>
<td valign="top" align="left">AT-rich interactive domain 1B</td>
<td valign="top" align="left">A component of the SWI/SNF chromatin remodeling complex and may play a role in cell cycle activation</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CDK12</td>
<td valign="top" align="left">Cyclin-dependent kinase 12</td>
<td valign="top" align="left">Transcriptional regulation of genomic stability, cell cycle and cell differentiation</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">ILF3</td>
<td valign="top" align="left">Interleukin enhancer binding factor 3</td>
<td valign="top" align="left">A double-stranded RNA-binding protein that forms a heterodimer with transcription factor ILF2 required for T-cell expression of interleukin 2</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IRF2BP</td>
<td valign="top" align="left">Interferon regulatory factor 2 binding protein 2</td>
<td valign="top" align="left">An interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">KDM6B</td>
<td valign="top" align="left">Lysine demethylase 6B</td>
<td valign="top" align="left">A histone H3-K27 demethylase involved in positive regulation of transcription</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">NSD1</td>
<td valign="top" align="left">Nuclear receptor binding SET domain protein 1</td>
<td valign="top" align="left">A histone methyltransferase which may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">TRIM24</td>
<td valign="top" align="left">Tripartite motif containing 24</td>
<td valign="top" align="left">A member of the tripartite motif family and mediates transcriptional control by interaction with the activation function 2 region of several nuclear receptors</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP47</td>
<td valign="top" align="left">ARID2</td>
<td valign="top" align="left">AT-rich interactive domain 2</td>
<td valign="top" align="left">A subunit of the PBAF chromatin-remodeling complex which facilitates ligand-dependent transcriptional activation by nuclear receptors</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">HDAC2</td>
<td valign="top" align="left">Histone deacetylase 2</td>
<td valign="top" align="left">Responsible for the deacetylation of lysine residues at the N-terminal regions of core histones and forms transcriptional repressor complexes by associating with many different proteins</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">STAT5A</td>
<td valign="top" align="left">Signal transducer and activator of transcription 5A</td>
<td valign="top" align="left">A member of the STAT family of transcription factors</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">STAT6</td>
<td valign="top" align="left">Signal transducer and activator of transcription 6</td>
<td valign="top" align="left">A member of the STAT family of transcription factors</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">TFEC</td>
<td valign="top" align="left">Transcription factor EC</td>
<td valign="top" align="left">A member of the micropthalmia family of basic helix-loop-helix leucine zipper transcription factors which regulate the expression of target genes by binding to E-box recognition sequences</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP32</td>
<td valign="top" align="left">DAZAP2</td>
<td valign="top" align="left">DAZ-associated protein 2</td>
<td valign="top" align="left">A coactivator of transcription factor TCF4 in canonical Wnt pathway</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">HHEX</td>
<td valign="top" align="left">Hematopoietically expressed homeobox</td>
<td valign="top" align="left">Hematopoietic cell differentiation</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP120/TRP47</td>
<td valign="top" align="left">PCGF5</td>
<td valign="top" align="left">Polycomb group ring finger 5</td>
<td valign="top" align="left">A component of the polycomb repressive complex which mediates epigenetic regulation</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>TRP-interacting targets include some host proteins involved in protein posttranslational modification (PTM). In particular, TRP120 interacts with 10 host proteins that have the main function in posttranslational modification machinery, including phosphorylation and ubiquitination. TRP120 interacts with host kinase and phosphatase involved in protein phosphorylation/dephosphorylation, including BMP2 inducible kinase (BMP2K), CDC-like kinase 1 (CLK1), and protein phosphatase 6 regulatory subunit 1 (PPP6R1). TRP120 also interacts with multiple host proteins involved in protein ubiquitination, including BTB domain containing 6 (BTBD6), a putative ubiquitin ligase adaptor protein (Sobieszczuk et al., <xref ref-type="bibr" rid="B40">2010</xref>); cullin-associated and neddylation dissociated 1 (CAND1), an essential regulator of Cullin-RING ubiquitin ligases (Goldenberg et al., <xref ref-type="bibr" rid="B14">2004</xref>); FBXW7, one of the four subunits of ubiquitin protein ligase complex SCFs (SKP1-cullin-F-box) (Hao et al., <xref ref-type="bibr" rid="B15">2007</xref>); kelch-like family member 12 (KLHL12), a substrate adaptor of the Cullin-3 ubiquitin ligase complex (Jin et al., <xref ref-type="bibr" rid="B18">2012</xref>); OTU deubiquitinase, ubiquitin aldehyde binding 1 (OTUB1), a highly specific ubiquitin iso-peptidase (Edelmann et al., <xref ref-type="bibr" rid="B10">2009</xref>); and an ubiquitin precursor protein ubiquitin C (UBC). Ubiquitin B (UBB), another ubiquitin precursor, is a common interacting target of TRP120 and TRP47. TRP47 also interacts with NEDD4 binding protein 1 (N4BP1), an inhibitor of the E3 ubiquitin ligase (Oberst et al., <xref ref-type="bibr" rid="B35">2007</xref>). Moreover, TRP120 has recently been found to be directly modified by SUMO, and more importantly, SUMO conjugation contributes to interactions with defined host proteins, such as PCGF5, actin and myosin cytoskeleton components, and recruitments of host proteins to the ehrlichial vacuole that influence infection (Dunphy et al., <xref ref-type="bibr" rid="B9">2014</xref>). It remains unclear whether the functional consequences of TRP ubiquitination and phosphorylation are different from those associated with TRP SUMOylation, but it is well-established that many bacterial effectors mimic host proteins involved in the host posttranslational machinery to modify host proteins and signaling (Ribet and Cossart, <xref ref-type="bibr" rid="B38">2010</xref>). Thus, PTMs may contribute to the moonlighting function of <italic>Ehrlichia</italic> TRPs and facilitate many diverse interactions between TRPs and host proteins. Another intracellular bacterium moonlighting effector is <italic>Chlamydia trachomatis</italic> CPAF, a protease which targets multiple host and bacterial proteins to maintain vacuole integrity, manipulate signaling pathways and promote virulence (Jorgensen et al., <xref ref-type="bibr" rid="B19">2011</xref>; Zhong, <xref ref-type="bibr" rid="B50">2011</xref>). Our RNAi data demonstrate that knockdown of all TRP target proteins involved in PTM significantly influenced infection, indicating that <italic>E. chaffeensis</italic> exploits major posttranslational modification machineries of host cells to facilitate a survival strategy.</p>
<p>Host proteins involved in metabolism are also frequent interacting targets of <italic>E. chaffeensis</italic> TRPs, including 16 TRP120-interacting proteins, six TRP47-interacting proteins, and five TRP32-interacting proteins. This category covers a variety of host metabolism processes, including glycometabolism, lipid metabolism, protein metabolism, nucleic acid metabolism, ion, and other inorganic metabolism. Two proteins, carbonic anhydrase I (CA1) and Charcot-Leyden crystal galectin (CLC) are common interacting targets of TRP120 and TRP47, suggesting their importance during infection. Our RNAi data demonstrated that knockdown of most of these <italic>Ehrlichia</italic> TRP target proteins significantly influenced bacterial load, indicating that TRPs also play a role in regulating host metabolism to favor the survival.</p>
<p>Interestingly, Y2H studies also discovered that a large number of apoptosis-associated proteins of the host cell were TRP targets, although most of these proteins are classified into other categories of function because their primary functions appear not to be related to apoptosis (Table <xref ref-type="table" rid="T7">7</xref>). Two TRP32-interacting proteins glucocorticoid-induced 1 (GLCCI1) and tumor protein p53 inducible protein 11 (TP53I11) have main function in cell apoptosis. Expression of GLCCI1 is induced by glucocorticoids and may be an early marker for glucocorticoid-induced apoptosis (Chapman et al., <xref ref-type="bibr" rid="B6">1996</xref>). TP53I11 is a downstream target of p53 and is involved in the regulation of apoptosis (Wu et al., <xref ref-type="bibr" rid="B46">2009</xref>). Three common interacting proteins of TRPs, eukaryotic elongation factor 1 alpha 1 (EEF1A1), CA1, and CLC, play roles in apoptosis (Ejiri, <xref ref-type="bibr" rid="B11">2002</xref>; Kubach et al., <xref ref-type="bibr" rid="B20">2007</xref>; Zheng et al., <xref ref-type="bibr" rid="B49">2015</xref>). In addition, TRPs interact with a wide variety of immunoglobulin molecules, such as IGKC, immunoglobulin heavy constant alpha 1 (IGHA1) and immunoglobulin lambda like polypeptide 5 (IGLL5), which have also been linked to apoptosis (Yang et al., <xref ref-type="bibr" rid="B48">2009</xref>). TRP47 interacts with other seven host proteins associated with apoptosis, for example, STAT5A and STAT6, both of which are members of the STAT family of transcription factors and have been found to induce the expression of anti-apoptotic protein BCL2L1/BCL-XL (Cal&#x000F2; et al., <xref ref-type="bibr" rid="B4">2003</xref>); and CAP1, which has been implicated in promoting apoptosis by functioning as an actin shuttle to mitochondria (Wang et al., <xref ref-type="bibr" rid="B45">2008</xref>). TRP120 interacts with relatively more apoptosis-associated proteins of the host cell. For example, CXCL12 is a negative regulator of intrinsic apoptotic signaling pathway in response to DNA damage, and FBXW7, in contrast, is a positive regulator of oxidative stress-induced intrinsic apoptotic signaling pathway (Hattermann et al., <xref ref-type="bibr" rid="B16">2010</xref>). Previous studies have demonstrated that host cell apoptosis is delayed by stabilization of the mitochondrial membrane potential during <italic>E. chaffeensis</italic> and <italic>E. ewingii</italic> infection (Xiong et al., <xref ref-type="bibr" rid="B47">2008</xref>; Liu et al., <xref ref-type="bibr" rid="B27">2011</xref>). Our RNAi data showed that knockdown of all apoptosis-associated TRP target proteins (except for DEAD-box helicase 5 [DDX5]) significantly influenced bacterial load, thus, the interactions of TRPs with different apoptosis-associated proteins may serve an opposite function by inhibiting or promoting apoptosis in the different stages of infection, to facilitate ehrlichial survival and release, respectively.</p>
<table-wrap position="float" id="T7">
<label>Table 7</label>
<caption><p><bold><italic><bold>E. chaffeensis</bold></italic> TRP-interacting host proteins involved in cell apoptosis</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left"><bold>TRP</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Host protein</bold></th>
<th valign="top" align="left"><bold>Main function</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="left"><bold>Symbol</bold></th>
<th valign="top" align="left"><bold>Full name</bold></th>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">TRP120</td>
<td valign="top" align="left">ICAM3</td>
<td valign="top" align="left">Intercellular adhesion molecule 3</td>
<td valign="top" align="left">Vesicle trafficking</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">SPTA1</td>
<td valign="top" align="left">Spectrin alpha, erythrocytic 1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">ADAM17</td>
<td valign="top" align="left">ADAM metallopeptidase domain 17</td>
<td valign="top" align="left">Cell signaling</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CXCL12</td>
<td valign="top" align="left">C-X-C motif chemokine ligand 12</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">KRAS</td>
<td valign="top" align="left">KRAS proto-oncogene, GTPase</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">LGALS1</td>
<td valign="top" align="left">Galectin 1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">PDE1B</td>
<td valign="top" align="left">Phosphodiesterase 1B</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">PPP3R1</td>
<td valign="top" align="left">Protein phosphatase 3 regulatory subunit B, alpha</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">DDX5</td>
<td valign="top" align="left">DEAD-box helicase 5</td>
<td valign="top" align="left">Transcriptional regulation</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IRF2BP</td>
<td valign="top" align="left">Interferon regulatory factor 2 binding protein 2</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">KDM6B</td>
<td valign="top" align="left">Lysine demethylase 6B</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">TRIM24</td>
<td valign="top" align="left">Tripartite motif containing 24</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">CAT</td>
<td valign="top" align="left">Catalase</td>
<td valign="top" align="left">Metabolism</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">FBXW7</td>
<td valign="top" align="left">F-box and WD repeat domain containing 7</td>
<td valign="top" align="left">Posttranslational modification</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">ERAL1</td>
<td valign="top" align="left">Era-like 12S mitochondrial rRNA chaperone 1</td>
<td valign="top" align="left">Others</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">ORAOV1</td>
<td valign="top" align="left">Oral cancer overexpressed 1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">SEPX1</td>
<td valign="top" align="left">Selenoprotein X, 1</td>
<td/>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP47</td>
<td valign="top" align="left">CDK1</td>
<td valign="top" align="left">Cyclin dependent kinase 1</td>
<td valign="top" align="left">Cell signaling</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">GNB1</td>
<td valign="top" align="left">G protein subunit beta 1</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">PTPN2</td>
<td valign="top" align="left">Protein tyrosine phosphatase, non-receptor type 2</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">HDAC2</td>
<td valign="top" align="left">Histone deacetylase 2</td>
<td valign="top" align="left">Transcriptional regulation</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">STAT5A</td>
<td valign="top" align="left">Signal transducer and activator of transcription 5A</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">STAT6</td>
<td valign="top" align="left">Signal transducer and activator of transcription 6</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">CAP1</td>
<td valign="top" align="left">Adenylate cyclase associated protein 1</td>
<td valign="top" align="left">Vesicle trafficking and intracellular transport</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP32</td>
<td valign="top" align="left">CD14</td>
<td valign="top" align="left">CD14 molecule</td>
<td valign="top" align="left">Cell signaling</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">GLCCI1</td>
<td valign="top" align="left">Glucocorticoid-induced 1</td>
<td valign="top" align="left">Apoptosis</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">TP53I11</td>
<td valign="top" align="left">Tumor protein p53 inducible protein 11</td>
<td/>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP120/TRP47</td>
<td valign="top" align="left">CA1</td>
<td valign="top" align="left">Carbonic anhydrase 1</td>
<td valign="top" align="left">Metabolism</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">CLC</td>
<td valign="top" align="left">Charcot-Leyden crystal galectin</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="left">IGKC</td>
<td valign="top" align="left">Immunoglobulin kappa constant</td>
<td valign="top" align="left">Cell signaling</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">TRP120/TRP32</td>
<td valign="top" align="left">EEF1A1</td>
<td valign="top" align="left">Eukaryotic translation elongation factor 1 alpha 1</td>
<td valign="top" align="left">Others</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IGHA1</td>
<td valign="top" align="left">Immunoglobulin heavy constant alpha 1</td>
<td valign="top" align="left">Cell signaling</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">IGLL5</td>
<td valign="top" align="left">Immunoglobulin lambda like polypeptide 5</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>We classified TRP-interacting host proteins according to their main functions, but many of them are moonlighting proteins which could be included in multiple categories. For example, EEF1A1, a common target protein of TRP120 and TRP32, is the second most abundant protein in eukaryotes after actin. It is an isoform of the alpha subunit of the elongation factor-1 complex, so its main function is the enzymatic delivery of aminoacyl tRNAs to the ribosome during protein translation; however, EEF1A1 is also one of the most important multifunctional eukaryotic proteins and has been reported to be involved in regulation of transcription, cytoskeletal remodeling, cellular response to epidermal growth factor stimulus, regulation of chaperone-mediated autophagy, and apoptosis (Condeelis, <xref ref-type="bibr" rid="B7">1995</xref>; Ejiri, <xref ref-type="bibr" rid="B11">2002</xref>). IGKC, another common target protein of TRP120 and TRP47, is the immunoglobulin kappa constant domain, so its main function is immune response including antigen binding, immunoglobulin receptor binding and complement activation, but it also appears to be involved in other signaling pathways, vesicle-mediated transport, receptor-mediated endocytosis, and phagocytosis (Bentley and Rabbitts, <xref ref-type="bibr" rid="B2">1980</xref>). It is not clear if all or part of the functions of these proteins are involved in <italic>Ehrlichia</italic> infection, but some of them are very likely moonlighting when interacting with TRPs, since they belong to multiple important common categories of TRP-interacting proteins, such as cell signaling, transcriptional regulation, vesicle trafficking and apoptosis. In addition, some putative host proteins interact with two TRPs, including EF1A1, IGHA1, IGLL5 (interacting with both TRP32 and TRP120), PCGF5, IGKC, CA1, CLC, and UBB (with TRP47 and TRP120), implicating the importance of not only the moonlighting and overlapping host targets but also the crosstalking and converging cellular networks by <italic>Ehrlichia</italic> effectors.</p>
<p>Our siRNA experiments revealed that knockdown of TRP-interacting host proteins could either increase or decrease <italic>E. chaffeensis</italic> load. Most siRNAs decreased the bacterial load, indicating that these proteins are necessary for <italic>Ehrlichia</italic> infection; however, siRNAs of 18 TRP120-interacting proteins and one TRP47-interacting protein (PCGF5) increased the bacterial load, indicating that these proteins inhibit the <italic>Ehrlichia</italic> infection. For example, Golgi associated gamma adaptin ear containing ARF binding protein 1 (GGA1) is a ubiquitous coat protein that regulates the protein trafficking between the trans-Golgi network and the endosome/lysosome system (Bonifacino, <xref ref-type="bibr" rid="B3">2004</xref>), so <italic>E. chaffeensis</italic> may inactivate GGA1 to prevent early endosomal maturation into late endosomes and then fusion with lysosome. PCGF5 is a component of the polycomb repressive complex which controls expression of many developmental regulator genes (Gao et al., <xref ref-type="bibr" rid="B13">2014</xref>), thus, <italic>E. chaffeensis</italic> may inhibit this transcriptional repressor in order to modulate host cell gene expression to favor ehrlichial survival. Uniquely, knockdown of many TRP120 host targets promoted infection, suggesting that TRP120 plays a role in modulating levels of these targets during infection. This result is likely related to our recent finding that TRP120 can function as ubiquitin ligase and degrade host target proteins such as PCGF5 (Zhu and McBride unpublished). In this study, no siRNA of TRP32-interacting proteins was found to increase the bacterial load significantly, probably because only C-terminus of TRP32 was available as the bait of Y2H screening and resulted in the loss of some host proteins interacting with other domains of TRP32. In addition, siRNAs of 14 TRP-interacting proteins could not change bacterial load significantly. This is probably because these proteins are important at the late stage of <italic>Ehrlichia</italic> infection, or they play a nonessential role in infection. Some of these proteins may be too abundant to be reduced sufficiently, or they are just nonspecific Y2H targets. We did not perform the late time point of infection in our experiments, since some infected cells started to collapse and release <italic>Ehrlichia</italic> at 3 day p.i.</p>
<p>Our RNAi data also show that changes in <italic>Ehrlichia</italic> infection status can occur at different stages of infection for different host proteins, suggesting that <italic>Ehrlichia</italic> TRPs and host proteins interact at different time points during infection. For example, some siRNAs, such as those targeting CDC42SE2, ITGAM, MYO10, unc-13 homolog D (UNC13D) and TLE4, reduced bacterial load significantly at 2 days p.i. but not significantly at day 1, suggesting that these proteins may be not involved in bacterial internalization or early stage of infection. In contrast, some siRNAs, such as those targeting solute carrier family 2 member 3 (SLC2A3), interferon gamma receptor 2 (IFNGR2), PDE1B, ARID1B, and EIF3A, reduced or increased bacterial load significantly at 1 day p.i. but not significantly at day 2, suggesting that these proteins are more important for the bacterial internalization or early stage of infection. Meanwhile, most siRNAs reduced or increased bacterial load significantly at both 1 and 2 days p.i., suggesting that these proteins are important for both early and intermediate stages of infection. Moreover, knockdown of some TRP-interacting proteins had a dramatic effect on infection, suggesting that they play key roles. For example, knockdown of SPTA1, ILF3, CLC, UBB, SEPX1, and PCGF5 reduced or increase the infection very significantly at both 1 and 2 days p.i., suggesting that they are critical factors exploited by <italic>Ehrlichia</italic> TRPs for bacterial survival; however, we cannot exclude the possibility that siRNAs may have different knockdown efficiency. We also found that the knockdown of any single target protein by RNA interference could not abolish the ehrlichial growth completely. As observed by Western blot, 100% knockdown of a target protein by siRNA is very difficult, thus, a knockout cell line would be necessary to determine if a host protein is essential for <italic>E. chaffeensis</italic> infection.</p>
<p>The molecular mechanisms by which <italic>Ehrlichia</italic> enters and survives in the host cell remain unclear. This study documents the extensive effector-host interactions that contribute to survival of this obligately intracellular pathogen, and will help understand the molecular mechanisms utilized by other intracellular pathogens to infect host cells. Further studies will delineate the specific roles of these complex and diverse TRP-host interactions during infection.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>TL and PD designed, performed the experiments and analyzed the data. TL wrote the manuscript. JM directed and contributed to the writing of the manuscript.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This work was supported by grants AI106859 and AI126144 from the National Institute of Allergy and Infectious Diseases (NIAID), and by funding from the Clayton Foundation for Research (to JM).</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname> <given-names>R. N.</given-names></name> <name><surname>Levenhagen</surname> <given-names>M. A.</given-names></name> <name><surname>Levenhagen</surname> <given-names>M. M.</given-names></name> <name><surname>Rieck</surname> <given-names>S. E.</given-names></name> <name><surname>Labruna</surname> <given-names>M. B.</given-names></name> <name><surname>Beletti</surname> <given-names>M. E.</given-names></name></person-group> (<year>2014</year>). <article-title>The spreading process of <italic>Ehrlichia canis</italic> in macrophages is dependent on actin cytoskeleton, calcium and iron influx and lysosomal evasion</article-title>. <source>Vet. Microbiol.</source> <volume>168</volume>, <fpage>442</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2013.11.030</pub-id><pub-id pub-id-type="pmid">24378068</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bentley</surname> <given-names>D. L.</given-names></name> <name><surname>Rabbitts</surname> <given-names>T. H.</given-names></name></person-group> (<year>1980</year>). <article-title>Human immunoglobulin variable region genes&#x02013;DNA sequences of two V kappa genes and a pseudogene</article-title>. <source>Nature</source> <volume>288</volume>, <fpage>730</fpage>&#x02013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1038/288730a0</pub-id><pub-id pub-id-type="pmid">6779204</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonifacino</surname> <given-names>J. S.</given-names></name></person-group> (<year>2004</year>). <article-title>The GGA proteins: adaptors on the move</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>5</volume>, <fpage>23</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1279</pub-id><pub-id pub-id-type="pmid">14708007</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cal&#x000F2;</surname> <given-names>V.</given-names></name> <name><surname>Migliavacca</surname> <given-names>M.</given-names></name> <name><surname>Bazan</surname> <given-names>V.</given-names></name> <name><surname>Macaluso</surname> <given-names>M.</given-names></name> <name><surname>Buscemi</surname> <given-names>M.</given-names></name> <name><surname>Gebbia</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>STAT proteins: from normal control of cellular events to tumorigenesis</article-title>. <source>J. Cell. Physiol.</source> <volume>197</volume>, <fpage>157</fpage>&#x02013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.10364</pub-id><pub-id pub-id-type="pmid">14502555</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cargnello</surname> <given-names>M.</given-names></name> <name><surname>Roux</surname> <given-names>P. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>75</volume>, <fpage>50</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00031-10</pub-id><pub-id pub-id-type="pmid">21372320</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname> <given-names>M. S.</given-names></name> <name><surname>Askew</surname> <given-names>D. J.</given-names></name> <name><surname>Kuscuoglu</surname> <given-names>U.</given-names></name> <name><surname>Miesfeld</surname> <given-names>R. L.</given-names></name></person-group> (<year>1996</year>). <article-title>Transcriptional control of steroid-regulated apoptosis in murine thymoma cells</article-title>. <source>Mol. Endocrinol.</source> <volume>10</volume>, <fpage>967</fpage>&#x02013;<lpage>978</lpage>. <pub-id pub-id-type="pmid">8843413</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Condeelis</surname> <given-names>J.</given-names></name></person-group> (<year>1995</year>). <article-title>Elongation factor 1 alpha, translation and the cytoskeleton</article-title>. <source>Trends Biochem. Sci.</source> <volume>20</volume>, <fpage>169</fpage>&#x02013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/S0968-0004(00)88998-7</pub-id><pub-id pub-id-type="pmid">7610475</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname> <given-names>C. K.</given-names></name> <name><surname>Nethery</surname> <given-names>K. A.</given-names></name> <name><surname>Popov</surname> <given-names>V. L.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Differentially expressed and secreted major immunoreactive protein orthologs of <italic>Ehrlichia canis</italic> and <italic>E. chaffeensis</italic> elicit early antibody responses to epitopes on glycosylated tandem repeats</article-title>. <source>Infect. Immun.</source> <volume>74</volume>, <fpage>711</fpage>&#x02013;<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.74.1.711-720.2006</pub-id><pub-id pub-id-type="pmid">16369028</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunphy</surname> <given-names>P. S.</given-names></name> <name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Ehrlichia chaffeensis</italic> exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival</article-title>. <source>Infect. Immun.</source> <volume>82</volume>, <fpage>4154</fpage>&#x02013;<lpage>4168</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01984-14</pub-id><pub-id pub-id-type="pmid">25047847</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edelmann</surname> <given-names>M. J.</given-names></name> <name><surname>Iph&#x000F6;fer</surname> <given-names>A.</given-names></name> <name><surname>Akutsu</surname> <given-names>M.</given-names></name> <name><surname>Altun</surname> <given-names>M.</given-names></name> <name><surname>di Gleria</surname> <given-names>K.</given-names></name> <name><surname>Kramer</surname> <given-names>H. B.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Structural basis and specificity of human otubain 1-mediated deubiquitination</article-title>. <source>Biochem. J.</source> <volume>418</volume>, <fpage>379</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20081318</pub-id><pub-id pub-id-type="pmid">18954305</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ejiri</surname> <given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization</article-title>. <source>Biosci. Biotechnol. Biochem.</source> <volume>66</volume>, <fpage>1</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.66.1</pub-id><pub-id pub-id-type="pmid">11866090</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farris</surname> <given-names>T. R.</given-names></name> <name><surname>Dunphy</surname> <given-names>P. S.</given-names></name> <name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Kibler</surname> <given-names>C. E.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Ehrlichia chaffeensis</italic> TRP32 is a nucleomodulin that directly regulates expression of host genes governing differentiation and proliferation</article-title>. <source>Infect. Immun.</source> <volume>84</volume>, <fpage>3182</fpage>&#x02013;<lpage>3194</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00657-16</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>Z.</given-names></name> <name><surname>Lee</surname> <given-names>P.</given-names></name> <name><surname>Stafford</surname> <given-names>J. M.</given-names></name> <name><surname>von Schimmelmann</surname> <given-names>M.</given-names></name> <name><surname>Schaefer</surname> <given-names>A.</given-names></name> <name><surname>Reinberg</surname> <given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>An AUTS2-Polycomb complex activates gene expression in the CNS</article-title>. <source>Nature</source> <volume>516</volume>, <fpage>349</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1038/nature13921</pub-id><pub-id pub-id-type="pmid">25519132</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname> <given-names>S. J.</given-names></name> <name><surname>Cascio</surname> <given-names>T. C.</given-names></name> <name><surname>Shumway</surname> <given-names>S. D.</given-names></name> <name><surname>Garbutt</surname> <given-names>K. C.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Xiong</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases</article-title>. <source>Cell</source> <volume>119</volume>, <fpage>517</fpage>&#x02013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.10.019</pub-id><pub-id pub-id-type="pmid">15537541</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname> <given-names>B.</given-names></name> <name><surname>Oehlmann</surname> <given-names>S.</given-names></name> <name><surname>Sowa</surname> <given-names>M. E.</given-names></name> <name><surname>Harper</surname> <given-names>J. W.</given-names></name> <name><surname>Pavletich</surname> <given-names>N. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases</article-title>. <source>Mol. Cell</source> <volume>26</volume>, <fpage>131</fpage>&#x02013;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.02.022</pub-id><pub-id pub-id-type="pmid">17434132</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hattermann</surname> <given-names>K.</given-names></name> <name><surname>Held-Feindt</surname> <given-names>J.</given-names></name> <name><surname>Lucius</surname> <given-names>R.</given-names></name> <name><surname>Muerkoster</surname> <given-names>S. S.</given-names></name> <name><surname>Penfold</surname> <given-names>M. E.</given-names></name> <name><surname>Schall</surname> <given-names>T. J.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects</article-title>. <source>Cancer Res.</source> <volume>70</volume>, <fpage>3299</fpage>&#x02013;<lpage>3308</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-3642</pub-id><pub-id pub-id-type="pmid">20388803</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname> <given-names>P.</given-names></name> <name><surname>Kalmar</surname> <given-names>T.</given-names></name> <name><surname>Arias</surname> <given-names>A. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Wnt/Notch signalling and information processing during development</article-title>. <source>Development</source> <volume>135</volume>, <fpage>411</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1242/dev.000505</pub-id><pub-id pub-id-type="pmid">18192283</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>L.</given-names></name> <name><surname>Pahuja</surname> <given-names>K. B.</given-names></name> <name><surname>Wickliffe</surname> <given-names>K. E.</given-names></name> <name><surname>Gorur</surname> <given-names>A.</given-names></name> <name><surname>Baumgartel</surname> <given-names>C.</given-names></name> <name><surname>Schekman</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Ubiquitin-dependent regulation of COPII coat size and function</article-title>. <source>Nature</source> <volume>482</volume>, <fpage>495</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/nature10822</pub-id><pub-id pub-id-type="pmid">22358839</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname> <given-names>I.</given-names></name> <name><surname>Bednar</surname> <given-names>M. M.</given-names></name> <name><surname>Amin</surname> <given-names>V.</given-names></name> <name><surname>Davis</surname> <given-names>B. K.</given-names></name> <name><surname>Ting</surname> <given-names>J. P.</given-names></name> <name><surname>McCafferty</surname> <given-names>D. G.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence</article-title>. <source>Cell Host Microbe</source> <volume>10</volume>, <fpage>21</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2011.06.008</pub-id><pub-id pub-id-type="pmid">21767809</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubach</surname> <given-names>J.</given-names></name> <name><surname>Lutter</surname> <given-names>P.</given-names></name> <name><surname>Bopp</surname> <given-names>T.</given-names></name> <name><surname>Stoll</surname> <given-names>S.</given-names></name> <name><surname>Becker</surname> <given-names>C.</given-names></name> <name><surname>Huter</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Human CD4&#x0002B;CD25&#x0002B; regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function</article-title>. <source>Blood</source> <volume>110</volume>, <fpage>1550</fpage>&#x02013;<lpage>1558</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-01-069229</pub-id><pub-id pub-id-type="pmid">17502455</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumagai</surname> <given-names>Y.</given-names></name> <name><surname>Matsuo</surname> <given-names>J.</given-names></name> <name><surname>Hayakawa</surname> <given-names>Y.</given-names></name> <name><surname>Rikihisa</surname> <given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Cyclic di-GMP signaling regulates invasion by <italic>Ehrlichia chaffeensis</italic> of human monocytes</article-title>. <source>J. Bacteriol.</source> <volume>192</volume>, <fpage>4122</fpage>&#x02013;<lpage>4133</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00132-10</pub-id><pub-id pub-id-type="pmid">20562302</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuriakose</surname> <given-names>J. A.</given-names></name> <name><surname>Miyashiro</surname> <given-names>S.</given-names></name> <name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Ehrlichia chaffeensis</italic> transcriptome in mammalian and arthropod hosts reveals differential gene expression and post transcriptional regulation</article-title>. <source>PLoS ONE</source> <volume>6</volume>:<fpage>e24136</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0024136</pub-id><pub-id pub-id-type="pmid">21915290</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuriakose</surname> <given-names>J. A.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular basis of antibody mediated immunity against <italic>Ehrlichia chaffeensis</italic> involves species-specific linear epitopes in tandem repeat proteins</article-title>. <source>Microbes Infect.</source> <volume>14</volume>, <fpage>1054</fpage>&#x02013;<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2012.05.012</pub-id><pub-id pub-id-type="pmid">22658957</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>M.</given-names></name> <name><surname>Rikihisa</surname> <given-names>Y.</given-names></name></person-group> (<year>2004</year>). <article-title><italic>Ehrlichia chaffeensis</italic> downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-&#x003BA;B, ERK 1/2 and p38 MAPK in host monocytes</article-title>. <source>Cell. Microbiol.</source> <volume>6</volume>, <fpage>175</fpage>&#x02013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1046/j.1462-5822.2003.00355.x</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lina</surname> <given-names>T. T.</given-names></name> <name><surname>Dunphy</surname> <given-names>P. S.</given-names></name> <name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2016a</year>). <article-title><italic>Ehrlichia chaffeensis</italic> TRP120 activates canonical Notch signaling to downregulate TLR2/4 expression and promote intracellular survival</article-title>. <source>MBio</source> <volume>7</volume>, <fpage>e00672</fpage>&#x02013;<lpage>e00616</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.00672-16</pub-id><pub-id pub-id-type="pmid">27381289</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lina</surname> <given-names>T. T.</given-names></name> <name><surname>Farris</surname> <given-names>T.</given-names></name> <name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Mitra</surname> <given-names>S.</given-names></name> <name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2016b</year>). <article-title>Hacker within! <italic>Ehrlichia chaffeensis</italic> effector driven phagocyte reprogramming strategy</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>6</volume>:<fpage>58</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2016.00058</pub-id><pub-id pub-id-type="pmid">27303657</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Jiang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Popov</surname> <given-names>V. L.</given-names></name> <name><surname>Zhang</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Obligate intracellular bacterium <italic>Ehrlichia</italic> inhibiting mitochondrial activity</article-title>. <source>Microbes Infect.</source> <volume>13</volume>, <fpage>232</fpage>&#x02013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2010.10.021</pub-id><pub-id pub-id-type="pmid">21070861</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Dunphy</surname> <given-names>P. S.</given-names></name> <name><surname>Lina</surname> <given-names>T. T.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Ehrlichia chaffeensis</italic> exploits canonical and noncanonical host Wnt signaling pathways to stimulate phagocytosis and promote intracellular survival</article-title>. <source>Infect. Immun.</source> <volume>84</volume>, <fpage>686</fpage>&#x02013;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01289-15</pub-id><pub-id pub-id-type="pmid">26712203</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Kuriakose</surname> <given-names>J. A.</given-names></name> <name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Wakeel</surname> <given-names>A.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Ehrlichia chaffeensis</italic> TRP120 interacts with a diverse array of eukaryotic proteins involved in transcription, signaling, and cytoskeleton organization</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>4382</fpage>&#x02013;<lpage>4391</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.05608-11</pub-id><pub-id pub-id-type="pmid">21859857</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>Ehrlichia chaffeensis</italic> TRP32 interacts with host cell targets that influence intracellular survival</article-title>. <source>Infect. Immun.</source> <volume>80</volume>, <fpage>2297</fpage>&#x02013;<lpage>2306</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00154-12</pub-id><pub-id pub-id-type="pmid">22547548</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Mcbride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Major species-specific antibody epitopes of the <italic>Ehrlichia chaffeensis</italic> p120 and <italic>E. canis</italic> p140 orthologs in surface-exposed tandem repeat regions</article-title>. <source>Clin. Vaccine Immunol</source>. <volume>16</volume>, <fpage>982</fpage>&#x02013;<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00048-09</pub-id><pub-id pub-id-type="pmid">19420187</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Wakeel</surname> <given-names>A.</given-names></name> <name><surname>Popov</surname> <given-names>V. L.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2008</year>). <article-title>A variable-length PCR target protein of <italic>Ehrlichia chaffeensis</italic> contains major species-specific antibody epitopes in acidic serine-rich tandem repeats</article-title>. <source>Infect. Immun.</source> <volume>76</volume>, <fpage>1572</fpage>&#x02013;<lpage>1580</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01466-07</pub-id><pub-id pub-id-type="pmid">18212082</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohan Kumar</surname> <given-names>D.</given-names></name> <name><surname>Lin</surname> <given-names>M.</given-names></name> <name><surname>Xiong</surname> <given-names>Q.</given-names></name> <name><surname>Webber</surname> <given-names>M. J.</given-names></name> <name><surname>Kural</surname> <given-names>C.</given-names></name> <name><surname>Rikihisa</surname> <given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>EtpE binding to DNase X induces Ehrlichial entry via CD147 and hnRNP-K recruitment, followed by mobilization of N-WASP and actin</article-title>. <source>MBio</source> <volume>6</volume>:<fpage>e01541</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.01541-15</pub-id><pub-id pub-id-type="pmid">26530384</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohan Kumar</surname> <given-names>D.</given-names></name> <name><surname>Yamaguchi</surname> <given-names>M.</given-names></name> <name><surname>Miura</surname> <given-names>K.</given-names></name> <name><surname>Lin</surname> <given-names>M.</given-names></name> <name><surname>Los</surname> <given-names>M.</given-names></name> <name><surname>Coy</surname> <given-names>J. F.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title><italic>Ehrlichia chaffeensis</italic> uses its surface protein EtpE to bind GPI-anchored protein DNase X and trigger entry into mammalian cells</article-title>. <source>PLoS Pathog.</source> <volume>9</volume>:<fpage>e1003666</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003666</pub-id><pub-id pub-id-type="pmid">24098122</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oberst</surname> <given-names>A.</given-names></name> <name><surname>Malatesta</surname> <given-names>M.</given-names></name> <name><surname>Aqeilan</surname> <given-names>R. I.</given-names></name> <name><surname>Rossi</surname> <given-names>M.</given-names></name> <name><surname>Salomoni</surname> <given-names>P.</given-names></name> <name><surname>Murillas</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase itch</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>104</volume>, <fpage>11280</fpage>&#x02013;<lpage>11285</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0701773104</pub-id><pub-id pub-id-type="pmid">17592138</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paddock</surname> <given-names>C. D.</given-names></name> <name><surname>Childs</surname> <given-names>J. E.</given-names></name></person-group> (<year>2003</year>). <article-title><italic>Ehrlichia chaffeensis</italic>: a prototypical emerging pathogen</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>16</volume>, <fpage>37</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.16.1.37-64.2003</pub-id><pub-id pub-id-type="pmid">12525424</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Popov</surname> <given-names>V. L.</given-names></name> <name><surname>Yu</surname> <given-names>X.</given-names></name> <name><surname>Walker</surname> <given-names>D. H.</given-names></name></person-group> (<year>2000</year>). <article-title>The 120 kDa outer membrane protein of <italic>Ehrlichia chaffeensis</italic>: preferential expression on dense-core cells and gene expression in <italic>Escherichia coli</italic> associated with attachment and entry</article-title>. <source>Microb. Pathog.</source> <volume>28</volume>, <fpage>71</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1006/mpat.1999.0327</pub-id><pub-id pub-id-type="pmid">10644493</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribet</surname> <given-names>D.</given-names></name> <name><surname>Cossart</surname> <given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Post-translational modifications in host cells during bacterial infection</article-title>. <source>FEBS Lett.</source> <volume>584</volume>, <fpage>2748</fpage>&#x02013;<lpage>2758</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2010.05.012</pub-id><pub-id pub-id-type="pmid">20493189</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname> <given-names>S.</given-names></name> <name><surname>Kholodenko</surname> <given-names>B. N.</given-names></name> <name><surname>Smit</surname> <given-names>M. J.</given-names></name> <name><surname>Bruggeman</surname> <given-names>F. J.</given-names></name></person-group> (<year>2015</year>). <article-title>G protein-coupled receptor signaling networks from a systems perspective</article-title>. <source>Mol. Pharmacol.</source> <volume>88</volume>, <fpage>604</fpage>&#x02013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1124/mol.115.100057</pub-id><pub-id pub-id-type="pmid">26162865</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sobieszczuk</surname> <given-names>D. F.</given-names></name> <name><surname>Poliakov</surname> <given-names>A.</given-names></name> <name><surname>Xu</surname> <given-names>Q.</given-names></name> <name><surname>Wilkinson</surname> <given-names>D. G.</given-names></name></person-group> (<year>2010</year>). <article-title>A feedback loop mediated by degradation of an inhibitor is required to initiate neuronal differentiation</article-title>. <source>Genes Dev.</source> <volume>24</volume>, <fpage>206</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1101/gad.554510</pub-id><pub-id pub-id-type="pmid">20080956</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>S.</given-names></name> <name><surname>Popov</surname> <given-names>V. L.</given-names></name> <name><surname>Walker</surname> <given-names>D. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Exit mechanisms of the intracellular bacterium <italic>Ehrlichia</italic></article-title>. <source>PLoS ONE</source> <volume>5</volume>:<fpage>e15775</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015775</pub-id><pub-id pub-id-type="pmid">21187937</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wakeel</surname> <given-names>A.</given-names></name> <name><surname>Den Dulk-Ras</surname> <given-names>A.</given-names></name> <name><surname>Hooykaas</surname> <given-names>P. J.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Ehrlichia chaffeensis</italic> tandem repeat proteins and Ank200 are type 1 secretion system substrates related to the repeats-in-toxin exoprotein family</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>1</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2011.00022</pub-id><pub-id pub-id-type="pmid">22919588</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wakeel</surname> <given-names>A.</given-names></name> <name><surname>Kuriakose</surname> <given-names>J. A.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2009</year>). <article-title>An <italic>Ehrlichia chaffeensis</italic> tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle trafficking</article-title>. <source>Infect. Immun.</source> <volume>77</volume>, <fpage>1734</fpage>&#x02013;<lpage>1745</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00027-09</pub-id><pub-id pub-id-type="pmid">19273555</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wakeel</surname> <given-names>A.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>McBride</surname> <given-names>J. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Mass spectrometric analysis of <italic>Ehrlichia chaffeensis</italic> tandem repeat proteins reveals evidence of phosphorylation and absence of glycosylation</article-title>. <source>PLoS ONE</source> <volume>5</volume>:<fpage>e9552</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0009552</pub-id><pub-id pub-id-type="pmid">20209062</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Zhou</surname> <given-names>G. L.</given-names></name> <name><surname>Vedantam</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>P.</given-names></name> <name><surname>Field</surname> <given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial shuttling of CAP1 promotes actin- and cofilin-dependent apoptosis</article-title>. <source>J. Cell Sci.</source> <volume>121</volume>, <fpage>2913</fpage>&#x02013;<lpage>2920</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.023911</pub-id><pub-id pub-id-type="pmid">18716285</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>X. M.</given-names></name> <name><surname>Wang</surname> <given-names>X. J.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Liang</surname> <given-names>X. Q.</given-names></name> <name><surname>Cao</surname> <given-names>E. H.</given-names></name></person-group> (<year>2009</year>). <article-title>PIG<sub>11</sub> is involved in hepatocellular carcinogenesis and its over-expression promotes Hepg<sub>2</sub> cell apoptosis</article-title>. <source>Pathol. Oncol. Res.</source> <volume>15</volume>, <fpage>411</fpage>&#x02013;<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1007/s12253-008-9138-5</pub-id><pub-id pub-id-type="pmid">19096915</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>Q.</given-names></name> <name><surname>Bao</surname> <given-names>W.</given-names></name> <name><surname>Ge</surname> <given-names>Y.</given-names></name> <name><surname>Rikihisa</surname> <given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title><italic>Ehrlichia ewingii</italic> infection delays spontaneous neutrophil apoptosis through stabilization of mitochondria</article-title>. <source>J. Infect. Dis.</source> <volume>197</volume>, <fpage>1110</fpage>&#x02013;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1086/533457</pub-id><pub-id pub-id-type="pmid">18462160</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>S. B.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Wu</surname> <given-names>B. Y.</given-names></name> <name><surname>Wang</surname> <given-names>M. W.</given-names></name> <name><surname>Cai</surname> <given-names>C. H.</given-names></name> <name><surname>Cho</surname> <given-names>D. B.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue</article-title>. <source>Scand. J. Gastroenterol.</source> <volume>44</volume>, <fpage>1443</fpage>&#x02013;<lpage>1451</lpage>. <pub-id pub-id-type="doi">10.3109/00365520903369953</pub-id><pub-id pub-id-type="pmid">19883274</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>B.</given-names></name> <name><surname>Zhao</surname> <given-names>Y.</given-names></name> <name><surname>Gu</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>CA<sub>1</sub> contributes to microcalcification and tumourigenesis in breast cancer</article-title>. <source>BMC Cancer</source> <volume>15</volume>:<fpage>679</fpage>. <pub-id pub-id-type="doi">10.1186/s12885-015-1707-x</pub-id><pub-id pub-id-type="pmid">26459317</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname> <given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Chlamydia trachomatis</italic> secretion of proteases for manipulating host signaling pathways</article-title>. <source>Front. Microbiol.</source> <volume>2</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2011.00014</pub-id><pub-id pub-id-type="pmid">21687409</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Farris</surname> <given-names>T.</given-names></name> <name><surname>Milligan</surname> <given-names>S.</given-names></name> <name><surname>Chen</surname> <given-names>H. S.</given-names></name> <name><surname>Zhu</surname> <given-names>R. J.</given-names></name> <name><surname>Hong</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Rapid identification of ubiquitination and SUMOylation target sites by microfluidic peptide array</article-title>. <source>Biochem. Biophys. Rep.</source> <volume>5</volume>, <fpage>430</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrep.2016.02.003</pub-id><pub-id pub-id-type="pmid">27047992</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Kuriakose</surname> <given-names>J. A.</given-names></name> <name><surname>Luo</surname> <given-names>T.</given-names></name> <name><surname>Ballesteros</surname> <given-names>E.</given-names></name> <name><surname>Gupta</surname> <given-names>S.</given-names></name> <name><surname>Fofanov</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title><italic>Ehrlichia chaffeensis</italic> TRP120 binds a G&#x0002B;C-rich motif in host cell DNA and exhibits eukaryotic transcriptional activator function</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>4370</fpage>&#x02013;<lpage>4381</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.05422-11</pub-id><pub-id pub-id-type="pmid">21859854</pub-id></citation></ref>
</ref-list>
</back>
</article>